'IRDiRC Recognized Resources': A new mechanism to support scientists to conduct efficient, high-quality research for rare diseases

European Journal of Human Genetics

Volumn 25, Issue 2, 2017, Pages 162-165

  Lochmüller, Hanns ^a   Le Cam, Yann ^b   Jonker, Anneliene H ^c   Lau, Lilian Pl ^c   Baynam, Gareth ^d,e   Kaufmann, Petra ^f   Lasko, Paul ^g   Dawkins, Hugh Js ^h   Austin, Christopher P ^f   Boycott, Kym M ⁱ  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Plateforme Maladies Rares   (France)

^c INSERM   (France)

^d KING EDWARD MEMORIAL HOSPITAL   (Australia)

^e Western Australian Register of Developmental Anomalies   (Australia)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g MCGILL UNIVERSITY   (Canada)

^h DEPARTMENT OF HEALTH   (Australia)

ⁱ CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DATA BASE; HEALTH CARE POLICY; HUMAN; MEDICAL ONTOLOGY; MEDICAL RESEARCH; ORGANIZATION; PEER REVIEW; PRACTICE GUIDELINE; PRIORITY JOURNAL; RARE DISEASE; REVIEW; SOCIAL NETWORK; ECONOMICS; GENETICS; INFORMATION DISSEMINATION; INTERNATIONAL COOPERATION; MEDICAL GENETICS; MEDICAL SOCIETY; ORGANIZATION AND MANAGEMENT; RARE DISEASES; STANDARDS; TRANSLATIONAL RESEARCH;

GENETICS, MEDICAL; HUMANS; INFORMATION DISSEMINATION; INTERNATIONAL COOPERATION; PEER REVIEW; RARE DISEASES; SOCIETIES, MEDICAL; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84992365905     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2016.137     Document Type: Review

References (21)

1. IRDiRC. IRDiRC Policies & Guidelines, 2013. Available at http://www.irdirc.org/reportsguidelines/policies-guidelines/(accessed on 28 July 2016).
2. Aymé S: IRDiRC-recommended. Eur J Hum Genet 2016; 24: 955.
3. IRDiRC. IRDiRC Recognized Resources, 2016. Available at http://www.irdirc.org/activities/irdirc-recognized-resources/(accessed on 28 July 2016).
4. Mascalzoni D, Dove ES, Rubinstein Y, et al: International Charter of principles for sharing bio-specimens and data. Eur J Hum Genet 2015; 23: 721-728.
5. Global Alliance for Genomics and Health. Framework for responsible sharing of genomic and health-related data. Available at http://genomicsandhealth.org/framework (accessed on 28 July 2016).
6. Buske OJ, Girdea M, Dumitriu S, et al: PhenomeCentral: a portal for phenotypic and genotypic matchmaking of patients with rare genetic diseases. Hum Mutat 2015; 36: 931-940.
7. Chatzimichali EA, Brent S, Hutton B, et al: Facilitating collaboration in rare genetic disorders through effective matchmaking in DECIPHER. Hum Mutat 2015; 36: 941-949.
8. Global Alliance for Genomics and Health: GENOMICS. A federated ecosystem for sharing genomic, clinical data. Science 2016; 352: 1278-1280.
9. Philippakis AA, Azzariti DR, Beltran S, et al: The Matchmaker Exchange: a platform for rare disease gene discovery. Hum Mutat 2015; 36: 915-921.
10. Rath A, Olry A, Dhombres F, Brandt MM, Urbero B, Ayme S: Representation of rare diseases in health information systems: the Orphanet approach to serve a wide range of end users. Hum Mutat 2012; 33: 803-808.
11. OMIM. Online Mendelian Inheritance in Man. Available at http://www.omim.org/(accessed on 28 July 2016).
12. Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A: OMIM.org: Online Mendelian Inheritance in Man (OMIM), an online catalog of human genes and genetic disorders. Nucleic Acids Res 2015; 43: 789-798.
13. Vasant D, Chanas L, Malone J, et al: ORDO: an ontology connecting rare disease. Epidemiology and genetic data, 2014. Available at: http://www.orphadata.org/cgi-bin/inc/ordo-orphanet.inc.php (accessed on 28 July 2016).
14. Köhler S, Doelken SC, Mungall CJ, et al: The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Res 2014; 42: 966-974.
15. ICHPT. Proposal of a core set of terms to describe human phenotypes by the International Consortium of Human Phenotype Terminologies, 2015. Available at http://www.irdirc.org/wp-content/uploads/2015/09/Proposal-International-Consortium-of-Human-Phenotype-Terminologies.pdf (accessed on 28 July 2016).
16. Sárközy A, Bushby K, Béroud C, Lochmüller H: 157th ENMC International Workshop: patient registries for rare, inherited muscular disorders 25-27 January 2008 Naarden, The Netherlands. Neuromuscul Disord 2008; 18: 997-1001.
17. Bladen CL, Rafferty K, Straub V, et al: The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia. Hum Mutat 2013; 34: 1449-1457.
18. TREAT-NMD. Standards in preclinical efficacy studies. Available at http://www. treat-nmd.eu/research/preclinical/preclinical-efficacy-standards/(accessed on 28 July 2016).
19. Willmann R, De Luca A, Benatar M, et al: Enhancing translation: guidelines for standard pre-clinical experiments in mdx mice. Neuromuscul Disord 2012; 22: 43-49.
20. Rodger S, Lochmüller H, Tassoni A, et al: The TREAT-NMD care and trial site registry: an online registry to facilitate clinical research for neuromuscular diseases. Orphanet J Rare Dis 2013; 8: 171-183.
21. Heslop E, Csimma C, Straub V, et al: The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development. Orphanet J Rare Dis 2015; 10: 49-55.